On March 26, 2023, at the ATOMEXPO 2024 International Forum, a ceremony was held in the Sirius Federal Territory to sign a roadmap for the development of cooperation within the framework of the project for the construction of a nuclear medicine center in the Republic of Nicaragua.
The document was signed by Igor Obrubov, Director General of Rosatom Health Technologies JSC (a division of Rosatom State Corporation), and Oscar Vásquez, Director of Health Services of the Ministry of Health of the Republic of Nicaragua.
The parties agreed to implement a joint project for the construction of a nuclear medicine center in accordance with the most modern technologies. The main specialization of the future center will be the diagnosis and treatment of socially significant diseases, in particular, cancer.
In addition, the parties intend to exchange information and experience in the field of nuclear medicine and the use of radiation technologies in healthcare, and cooperate in the field of advanced training of medical workers.
“ROSATOM has a comprehensive approach to the implementation of tasks in the field of healthcare. Our activities include the production of isotopes and the production of radiopharmaceuticals, the development and production of high-tech medical equipment, and the construction of medical infrastructure facilities. We are pleased to assist the citizens of the Republic of Nicaragua in expanding opportunities for access to high technologies of peaceful nuclear energy for the preservation and promotion of health,” declared Igor Obrubov.
“ROSATOM’s skills in the creation of specialized medical infrastructure facilities give us every reason to be confident in the effective implementation of our joint project to create a nuclear medicine center in Nicaragua. This work will allow us to reach a qualitatively new level in the diagnosis and treatment of socially significant diseases and expand the opportunities for physicians and patients in Nicaragua to access modern nuclear medicine technologies,” said Oscar Vásquez.
For reference:
Rosatom Health Technologies JSC is a division that accumulates the expertise of Rosatom State Corporation in the field of medicine. The company was established on the basis of Rosatom’s enterprises and institutes with the aim of comprehensive development of medical technologies in Russia and abroad. The Health Technologies Division is developing in four main areas: integrated solutions for medicine; production and supply of isotope products (50 countries of the world); equipment for diagnostics and therapy; solutions for ionizing treatment of products.
The ATOMEXPO International Forum is one of the main events of the global nuclear industry, the largest exhibition and business platform where the current state of the nuclear industry is discussed and trends in its further development are formed. It has been held since 2009. At the exhibition, leading companies of the global nuclear industry and related sectors present their technologies and skills. As part of the demonstration of Rosatom’s commitment to the climate agenda, carbon footprint compensation will be provided at the XIII ATOMEXPO 2024 International Forum with the use of special certificates.
Russia is consistently developing international trade and economic relations, focusing on cooperation with friendly countries. Despite external constraints, the domestic economy is increasing its export potential, supplying goods, services and raw materials around the world. Rosatom and its enterprises take an active part in this work.
The document was signed by Igor Obrubov, Director General of Rosatom Health Technologies JSC (a division of Rosatom State Corporation), and Oscar Vásquez, Director of Health Services of the Ministry of Health of the Republic of Nicaragua.
The parties agreed to implement a joint project for the construction of a nuclear medicine center in accordance with the most modern technologies. The main specialization of the future center will be the diagnosis and treatment of socially significant diseases, in particular, cancer.
In addition, the parties intend to exchange information and experience in the field of nuclear medicine and the use of radiation technologies in healthcare, and cooperate in the field of advanced training of medical workers.
“ROSATOM has a comprehensive approach to the implementation of tasks in the field of healthcare. Our activities include the production of isotopes and the production of radiopharmaceuticals, the development and production of high-tech medical equipment, and the construction of medical infrastructure facilities. We are pleased to assist the citizens of the Republic of Nicaragua in expanding opportunities for access to high technologies of peaceful nuclear energy for the preservation and promotion of health,” declared Igor Obrubov.
“ROSATOM’s skills in the creation of specialized medical infrastructure facilities give us every reason to be confident in the effective implementation of our joint project to create a nuclear medicine center in Nicaragua. This work will allow us to reach a qualitatively new level in the diagnosis and treatment of socially significant diseases and expand the opportunities for physicians and patients in Nicaragua to access modern nuclear medicine technologies,” said Oscar Vásquez.
For reference:
Rosatom Health Technologies JSC is a division that accumulates the expertise of Rosatom State Corporation in the field of medicine. The company was established on the basis of Rosatom’s enterprises and institutes with the aim of comprehensive development of medical technologies in Russia and abroad. The Health Technologies Division is developing in four main areas: integrated solutions for medicine; production and supply of isotope products (50 countries of the world); equipment for diagnostics and therapy; solutions for ionizing treatment of products.
The ATOMEXPO International Forum is one of the main events of the global nuclear industry, the largest exhibition and business platform where the current state of the nuclear industry is discussed and trends in its further development are formed. It has been held since 2009. At the exhibition, leading companies of the global nuclear industry and related sectors present their technologies and skills. As part of the demonstration of Rosatom’s commitment to the climate agenda, carbon footprint compensation will be provided at the XIII ATOMEXPO 2024 International Forum with the use of special certificates.
Russia is consistently developing international trade and economic relations, focusing on cooperation with friendly countries. Despite external constraints, the domestic economy is increasing its export potential, supplying goods, services and raw materials around the world. Rosatom and its enterprises take an active part in this work.